Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Jail telehealth program aims to keep women off opioids after release

NCT ID NCT04069624

Disease control Sponsor: Michele Staton Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether offering medication for opioid use disorder (MOUD) via telehealth to women in jail helps them start treatment after release. 900 women across 9 Kentucky jails took part. Some also got a peer navigator for support. The goal was to see if these services increase treatment initiation and reduce relapse.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
medication for opioid use disorder (MOUD) via telehealth
What this could lead to
If successful, this approach could help more women leaving jail start and stay on opioid treatment, reducing relapse and return to custody.
What could go wrong
This is a completed study, but results may not apply to all settings. The intervention relies on jail resources and participant willingness, which can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

900 people

The number who actually took part.

Started

Dec 2020

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ASSIST opioid (prescription or street) score of 4+ * Willingness to participate in MOUD pre-treatment * Incarceration period of at least 7 days Exclusion Criteria • Cognitive impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid use disorder

Contacts and locations

Locations

  • Grant County Detention Center

    Williamstown, Kentucky, 41097, United States

  • Grayson County Detention Center

    Leitchfield, Kentucky, 42754, United States

  • Hardin County Detention Center

    Elizabethtown, Kentucky, 42701, United States

  • Harlan County Detention Center

    Harlan, Kentucky, 40828, United States

  • Henderson County Detention Center

    Henderson, Kentucky, 42420, United States

  • Laurel County Correctional Center

    London, Kentucky, 40741, United States

  • Marion County Detention Center

    Lebanon, Kentucky, 40033, United States

  • Pike County Detention Center

    Pikeville, Kentucky, 41501, United States

  • Shelby County Detention Center

    Shelbyville, Kentucky, 40065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.